Drreddys Laboratories | RDY - Sales Revenues


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Drreddys Laboratories

Drreddys Laboratories reported INR62.97B in Sales Revenues for its fiscal quarter ending in March of 2023.


Sales Change
ANI Pharmaceuticals ANIP:US USD 106.79M 12.55M
Bayer BAYN:GR EUR 14.39B 2.39B
Catalent CTLT:US USD 1.15B 127M
Cipla CIPLA:IN INR 57.39B 707.9M
Corcept Therapeutics CORT:US USD 105.65M 2.6M
Drreddys Laboratories RDY:US INR 62.97B 4.73B
Endo International ENDP:US USD 515.27M 40.54M
GlaxoSmithKline GSK:LN GBP 6.95B 425M
Hikma Pharmaceutical HIK:LN USD 1.3B 91M
Horizon Pharma HZNP:US USD 832.06M 109.97M
Lonza Group LONN:SW CHF 3.24B 259M
Novartis NOVN:VX USD 13.21B 207M
Pacira PCRX:US USD 160.34M 11.61M
Phibro Animal Health PAHC:US USD 245.67M 1.03M
Prestige Brands PBH:US USD 285.87M 10.34M
Richter Gedeon RICHT:HB HUF 209.65B 14.32B
Sun Pharmaceuticals SUNP:IN INR 109.31B 3.1B
Supernus Pharmaceuticals SUPN:US USD 153.76M 13.56M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 3.66B 223M